NEW YORK, Nov 2 - EraGen Biosciences said Thursday it will provide its SNP detection technology to the Novartis Agricultural Discovery Institute (NADII) for incorporation into a plant genotyping system the institute is developing.

“The idea is that we will work together on a system and then in good faith we will work out licensing agreements,” said EraGen CSO James Prudent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.